Health

72 views

Opko Health Inc. (NASDAQ:OPK) reported that the firm has registered the first patient in a Phase IIb dose...

78 views

Cytori Therapeutics Inc (NASDAQ:CYTX) reported the publication of preclinical report from a study utilizing Cytori Cell Therapy™ in...

OPKO Health Inc
103 views

Opko Health Inc. (NASDAQ:OPK) announced financial and operating report for the quarter closed September 30, 2017. Consolidated revenues...

688 views

Dextera Surgical Inc (NASDAQ:DXTR) a firm commercializing and developing the MicroCutter 5/80™ reported that revenue for the third...

188 views

Pain Therapeutics, Inc. (NASDAQ:PTIE) reported the completion of a Phase 1 clinical trial for PTI-125, which is an...

OPKO Health Inc
275 views

Opko Health Inc. (NASDAQ:OPK) reported that its subsidiary unit EirGen Pharma has finalized an exclusive deal with Japan...

216 views

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) reported strategies to expand its voclosoprin renal franchise to comprise focal segmental glomerulosclerosis and...

208 views

TG Therapeutics Inc (NASDAQ:TGTX) has completed full enrollment in the planned UNITY-CLL Phase III clinical study. The UNITY-CLL...

147 views

Ardelyx Inc (NASDAQ:ARDX) announced promising data from T3MPO-2, its second Phase III trial of tenapanor for IBS-C. The...

128 views

MannKind Corporation (NASDAQ:MNKD) has entered into definitive deals with certain institutional investors and other shareholders pertaining to a...